pharma news

News

Anthropic launches Claude Science for pharma researchers

Anthropic had made a big life sciences play with the launch of Claude Science, an AI 'workbench' for researchers involved in drug discovery.

News

Digital brain inside human head concept for Vistagen

Despite study bust, Vistagen still hopes to file anxiety dru...

Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.

News

Unicycive hits another hurdle with hyperphosphataemia drug

Unicycive Therapeutics' hopes of getting FDA approval of its drug for hyperphosphataemia in dialysis patients have been knocked back again.

News

Brukinsa data raises chemo-free hope for mantle cell lymphom...

Patients with newly diagnosed mantle cell lymphoma could avoid chemotherapy with a regimen based on BeOne's Brukinsa, according to the MANGROVE trial.

News

Sanofi eyes extending Nexviazyme into infantile Pompe

Armed with new phase 3 data, Sanofi will try to expand the US label of its Pompe disease drug Nexviazyme to include the severe infantile-onset form.

News

Lilly, Regeneron among firms chosen for FDA fast plant pilot

Eli Lilly, Regeneron, and five other drugmakers will take part in an FDA pilot designed to make it quicker and easier to set up manufacturing plants.

Anthropic launches Claude Science for pharma researchers

Despite study bust, Vistagen still hopes to file anxiety dru...

Unicycive hits another hurdle with hyperphosphataemia drug

Brukinsa data raises chemo-free hope for mantle cell lymphom...

Sanofi eyes extending Nexviazyme into infantile Pompe

Lilly, Regeneron among firms chosen for FDA fast plant pilot

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks